Author: Business Wire

Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today longer-term data from the Phase III open-label extension studies of OPERA I, OPERA II and ORATORIO showed that patients w…

L’Italie a déployé le système de dépistage oculaire basé sur l’IA EyeArt d’Eyenuk pour sa première campagne nationale de prévention et de diagnostic de la maculopathie rétinienne et diabétique

LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., une société mondiale de technologies et services médicaux basés sur l’intelligence artificielle (IA), qui se démarque en tant que leader des applications en situation réelle pour AI Eye Screening™, a annoncé a…

Italien hat das EyeArt-AI-Eye-Screening-System von Eyenuk für die erste nationale Präventions- und Diagnosekampagne für retinale und diabetische Makulopathie eingesetzt

LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., ein weltweit tätiges Unternehmen für Medizintechnik und Dienstleistungen im Bereich der künstlichen Intelligenz (KI) (englisch: Artificial Intelligence, AI) und Marktführer bei realen Anwendungen für AI-Eye-Sc…

Resumen: Italia presenta EyeArt, el sistema de examen ocular por IA de Eyenuk, para la primera campaña nacional de prevención y diagnóstico de la degeneración macular retiniana y diabética

LOS ÁNGELES–(BUSINESS WIRE)–Eyenuk Inc., compañía global de servicios y tecnología médicos impulsados por inteligencia artificial (IA) y líder en aplicaciones del mundo real para AI Eye Screening™, ha anunciado hoy que el sistema de examen ocular Eye…

Riassunto: Adottato in Italia per la prima campagna nazionale di diagnosi e prevenzione della retinopatia e maculopatia diabetica il sistema di screening oculare basato sull’intelligenza artificiale EyeArt di Eyenuk

LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., fornitore globale di tecnologie e servizi medici basati su intelligenza artificiale (artificial intelligence, AI) nonché leader nelle applicazioni nel mondo reale della tecnologia AI Eye Screening™, ha annunci…

Global Ophthalmic Devices Market Report 2019 – Analysis & Forecasts, 2014-2018 & 2019-2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmic Devices Market Forecast to 2022 provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmic devices market. The ophthalmic devices (or) equipment supplies market consists of sales of ophthalmic devices and related services by entities (organizations, sole traders and partne

Aerie Pharmaceuticals Announces Full Exercise by Initial Purchasers of Option to Purchase Additional $41.25 Million Aggregate Principal Amount of Aerie’s 1.50% Convertible Senior Notes Due 2024

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…

Global Electroretinograph Market by Product, Application and Geography – Forecast to 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Electroretinograph Market by Product, Application, and Geography – Global Forecast 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The electroretinograph market analysis considers sales from both fixed ERG, portable ERG. This analysis also considers the sales of electroretinograph in Asia, Europe, North America, and RoW. In 2018, the fixed ERG segment had a significant market share, and this trend is expected to continue over the forecast per

Global Ophthalmics Partnering Deal Trends, Players and Financials, 2014-Q3, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics Partnering 2014 to 2019 provides the full collection of Ophthalmics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology.

Immervisionがスマートフォン向けに最高解像度、超広角125° FoVの新パノモーフ・レンズを発表

モントリオール–(BUSINESS WIRE)–(ビジネスワイヤ) — モントリオールを拠点に特許取得済み広角光学・イメージング技術を開発・ライセンスするImmervisionは、スマートフォンとコンシューマーカメラのメーカー向けに、最高の解像度および像鮮明度を備え、業界初の超広角125°視野(FoV)のエッジトゥーエッジ・パノモーフ・レンズを発表します。 Immervisionの特許取得済み超広角レンズの新たなライセンシーとなった台湾企業のZhong Yang Technology Co.,…